Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Saturday, July 03, 2010
Which US Pharma are Sanofi buying for $20 billion?
The options market played host to a number of speculative and bullish trades in Genzyme, Biogen Idec and Botox maker Allergan amid reports that a French drug maker may pursue a major U.S. acquisition.